23 results
Bell's Phenomenon on Physical Exam

Carles Bell realized that when trying to close the eye on the
Bell's Phenomenon ... Exam Carles Bell ... neurologiabr #Bells ... Sign #clinical #video ... #PhysicalExam #ophthalmology
Bell's Palsy - Left Facial Nerve Palsy in a young child

#Bells #Palsy #Facial #Nerve #clinical #video
Bell's Palsy - Left ... young child #Bells ... Nerve #clinical #video ... #neurology #pediatrics
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
CD4 count <100 cells ... CD4 count >100 cells ... decreases to <100 cells ... Prevention #Treatment #management ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Treating Isospora belli ... Treating Isospora belli ... CD4 count >200 cells ... evidence of active I. belli ... #pharmacology
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
Antibodies (Plasma cells ... Medications #Therapies #Pharmacology ... #Management #Classes
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
Hypoglycemics in Diabetes Management ... - Stimulate β cells ... Sulfonylureas - ↑ β-cells ... Hypoglycemics #Diabetes #Management ... #pharmacology #
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
CD4 count <200 cells ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
-6 activates T cells ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
CD4 count <100 cells ... opportunistic #infections #HIVAIDS ... #management #pharmacology ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
CD4 count <200 cells ... >200 but <250 cells ... /mm3 to ≥200 cells ... opportunistic #infections #HIVAIDS ... #management #pharmacology